targeted cancer treatment
-
Coeptis Therapeutics’ Dave Mehalick on Making Cell Therapy Universally Accessible
April 30, 2024 — In a recent interview with InvestorNews, Dave Mehalick, Chairman, President, and CEO of Coeptis…
-
Dave Mehalick from Coeptis Therapeutics to Host InvestorTalk (04.25.2024)
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for Thursday, April 25th at 9 AM EST, featuring…
-
Coeptis CEO Dave Mehalick on NASDAQ listing and entering the Cancer Treatment Race
Innovative cell therapy platforms have the potential to disrupt conventional cancer treatment In an InvestorCoffee interview with host…
-
Focused on a better future, Siva’s cancer tumor therapy system selects Sona’s gold nanorod for delivery
Today we are going to talk about a company that is making progress in the targeted treatment of…